Spanish pharmaceutical company Grifols launched a $105 million private placement transaction Wednesday, with Mesirow Financial as its agent, a source familiar with the situation confirmed.

The deal will be structured as a sale leaseback on two properties based in Los Angeles and one in San Marcos, Texas. The issue, which will have a four-year average, five-year final maturity, is expected to price after April 18.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.